Home » Topics » BioWorld Science

BioWorld Science
RSS

Potent non-HAP class I HBV capsid assembly modulator ALG-005398 reduces HBsAg levels in vivo

Nov. 22, 2021

AL-009 shows antitumor efficacy both as monotherapy and in combination with anti-PD-L1

Nov. 22, 2021

U.S. researchers divulge new PI3K-alpha inhibitors

Nov. 22, 2021

Recurium IP Holdings presents new PROTACs for cancer

Nov. 22, 2021

Janssen Pharmaceutica synthesizes new IL-17A/IL-17RA interaction modulators

Nov. 22, 2021

Eli Lilly patents new Ret inhibitors

Nov. 22, 2021

Fochon Pharmaceuticals patents Bcl-2 inhibitors

Nov. 22, 2021

NTX-1088, anti-PVR MAb with exclusive triple mechanism of action

Nov. 22, 2021

LINC01348 as a potential new therapeutic target and biomarker in HCC

Nov. 22, 2021

In vivo studies of HRX-0215 in acute and chronic liver disease

Nov. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
Quince’s eDSP on ice after Neat phase III fails in A-T
BioWorld
Quince Therapeutics Inc. is scrapping work with dexamethasone sodium phosphate encapsulated in autologous erythrocytes (eDSP) for patients with...